where y i is a vector with n i observations of subject i, with i varying from 1 to N,  i is 1 the vector of the residual errors which is the part of the observations unexplained by the 2 model f. It is assumed that the errors  i are independent from one observation to another and 3 that their distribution is Gaussian  i ~ N(0; I ni ) , where I ni is an identity matrix of dimension n i .
4
a and b are two parameters characterizing the error model variance. To fit the data, we used 5 an additive error model:
, where y is the observed response, f is the model 6 function, a is the additive error term, and the error, , is normally distributed following 7 N(0,1). 8
In nonlinear mixed effect models, the model f is common to all the subjects, but the 9 vector of parameters θ i for subject i may vary from one subject to another. The inter-10 individual variability is modeled with the vector of random effect parameters  i .
11
The vector of parameters θ i for the subject i can then be expressed as a second-level 12 model which links with the function g, the vector of fixed effect parameters  common for all 13 subject and the vector of random effects b i specific for subject i: θ i = g(; i ). The vector of 14 random effect is assumed to follow a Gaussian distribution  i ~ N(0; Ω),  i and  i are 15 assumed to be independent for subject i and  i | i is assumed independent from one subject to 16 another. Ω is the matrix of random effect variance and covariances. The function g is here an 17 exponential model. The vector of parameters is hence written as = . 18
Parameter estimation and statistical methods. Population parameter estimates and 19
inter-individual variability (IIV) estimates were obtained using a maximum-likelihood 20 method implemented in MONOLIX version 4.3.3 (http://software.monolix.org), which uses 21 the stochastic approximation expectation-approximation (SAEM) algorithm 2 to estimate 22 population parameters. The VK model was fitted to log 10 viral load. HCV genotype, cohortto study their effect on the PK/VK parameters. Individual parameters were estimated using 1 the empirical Bayes method 3 . 2
The model was simultaneously fitted to VK, systemic and respiratory symptom data 3 since simultaneous fitting has been shown to provide more precise estimates 4, 5 . Parameters 4 estimated were b, p, , , ,  s ,  and . For each parameter, we report the population 5 estimates and their relative standard errors, as well as the inter-individual variability in 6 percent with its relative standard error (Table 1) . 7
Individual parameters were estimated using the empirical Bayes method 3 and are 8 presented in Tables S1. In the following we present only the significant results. 9
10

Dimension analysis 11
The ODEs compartments are the following: 
Practical identifiability results 4
To choose the values for these parameters, we re-estimated the parameters for every 5 combination of the following V 0 =0.1, 0.5 and 1.0 TCID 50 /mL, =0.5, 1.0 and 2.0 d -1 and 6 c=1.0, 3.0 and 10.0 d -1 . These values are in the same range as the parameter estimates 7 obtained in previous human vivo studies [6] [7] [8] . We chose the set that provided the smallest 8
Bayesian information criteria (BIC), where V 0 =0.5 TCID 50 /mL, =0.5 d -1 and c=1.0 d -1 (Fig.  9   S1 ). We found that four parameters, p, ,  S ,  S did not vary significantly between the 10 different fits and that infectivity rate, , tended to be lower whereas production of local 11 cytokines ( L ) and diffusion of cytokines to circulation () tended to be higher with lower 12 virus clearance, c. The effect of cytokines () tended to be higher with lower infected cell 13 mortality rate () (Fig. S1) Table S2 : Estimated correlation matrix of the random effects. The relative standard error (rse) is the ratio of the standard error divided by the average value and is computed for each population estimate and IIV. Figure S3 . Goodness of fit plots for viral titre (left), systemic symptoms (centre) and respiratory symptoms (right). The upper panels represent the observations vs. predictions, the black line is the line of identity, the blue line the spline and show that the model fits well the data. The central panels represent the Normalised prediction distribution errors (NPDE) vs. the predictions and show no trends in the distribution of the residual depending on the predictions and the lower panels represent the NPDE vs. time and show no trends in the distribution of the residual depending on the sample time. Overall these goodness of fit plots suggest that the model fits well the data. Figure S4 . Effect of parameters b and s on the infectiousness rank. Infectiousness is computed as the area under the curve of ( ) = ( )( + ( )) . Rank #1 is for the most infectious subject. Each line shows the evolution of a subject infectiousness rank for the different scenarios tested. ; System of ODE ddt_Tt = -beta*Tt*V ; Target cells ddt_I = beta*Tt*V -delta*I -eta*I*N ; Infected cells ddt_V = p/(1+psi*F)*I -c*V -sigma*beta*Tt*V ; Free virus ddt_F = gamma_S*I -alpha*F ; Local pro-inflammatory cytokines ddt_Fs = gamma_R*F-alphasys*Fs ; Systemic pro-inflammatory cytokines ddt_N = Fs ; Cytotoxicity LVL =max(log10(V),0) ; Log-transformed viral titre logistS =12*(Fs/(1+Fs)) ; Transformation of systemic pro-inflammatory cytokines levels into systemic symptom score logistR = 12*(F/(1+F)) ; Transformation of local pro-inflammatory cytokines levels into respiratory symptom score OUTPUT: output = {LVL, logistS, logistR} ; Fitting simultaneously viral titre and symptoms scores
